Clinical Research Directory
Browse clinical research sites, groups, and studies.
ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
Sponsor: Oruka Therapeutics, Inc.
Summary
This is a multicenter, randomized, double-blinded, placebo-controlled, proof-of-concept study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis.
Official title: A Multicenter, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-07-18
Completion Date
2027-05
Last Updated
2026-03-17
Healthy Volunteers
No
Conditions
Interventions
ORKA-001 Induction Dose
ORKA-001 Induction Dose, administered by subcutaneous (SC) injection
Placebo
Placebo administered by subcutaneous (SC) injection
ORKA-001 Maintenance Dose
ORKA-001 Maintenance Dose, administered by subcutaneous (SC) injection
Locations (26)
Oruka Therapeutics Investigative Site
Fountain Valley, California, United States
Oruka Therapeutics Investigative Site
Los Angeles, California, United States
Oruka Therapeutics Investigative Site
San Diego, California, United States
Oruka Therapeutics Investigative Site
Santa Ana, California, United States
Oruka Therapeutics Investigative Site
Santa Monica, California, United States
Oruka Therapeutics Investigative Site
Cromwell, Connecticut, United States
Oruka Therapeutics Investigative Site
Coral Gables, Florida, United States
Oruka Therapeutics Investigative Site
Rolling Meadows, Illinois, United States
Oruka Therapeutics Investigative Site
Bowling Green, Kentucky, United States
Oruka Therapeutics Investigative Site
Rockville, Maryland, United States
Oruka Therapeutics Investigative Site
Boston, Massachusetts, United States
Oruka Therapeutics Investigative Site
Detroit, Michigan, United States
Oruka Therapeutics Investigative Site
New York, New York, United States
Oruka Therapeutics Investigative Site
New York, New York, United States
Oruka Therapeutics Investigative Site
Portland, Oregon, United States
Oruka Therapeutics Investigative Site
Norfolk, Virginia, United States
Oruka Therapeutics Investigative Site
Milwaukee, Wisconsin, United States
Oruka Therapeutics Investigative Site
Edmonton, Alberta, Canada
Oruka Therapeutics Investigative Site
Edmonton, Alberta, Canada
Oruka Therapeutics Investigative Site
Surrey, British Columbia, Canada
Oruka Therapeutics Investigative Site
Hamilton, Ontario, Canada
Oruka Therapeutics Investigative Site
London, Ontario, Canada
Oruka Therapeutics Investigative Site
Markham, Ontario, Canada
Oruka Therapeutics Investigative Site
Peterborough, Ontario, Canada
Oruka Therapeutics Investigative Site
Toronto, Ontario, Canada
Oruka Therapeutics Investigative Site
Waterloo, Ontario, Canada